BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Norman K, Pirlich M. Gastrointestinal tract in liver disease: which organ is sick? Curr Opin Clin Nutr Metab Care. 2008;11:613-619. [PMID: 18685458 DOI: 10.1097/mco.0b013e32830a70bc] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Lun CY, Tsui SK. Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome. Int J Mol Sci. 2015;16:26263-26279. [PMID: 26540050 DOI: 10.3390/ijms161125957] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
2 Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 2012;18:337-46. [PMID: 23323248 DOI: 10.3350/cmh.2012.18.4.337] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
3 Papp M, Norman GL, Vitalis Z, Tornai I, Altorjay I, Foldi I, Udvardy M, Shums Z, Dinya T, Orosz P. Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? PLoS One. 2010;5:e12957. [PMID: 20886039 DOI: 10.1371/journal.pone.0012957] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
4 邓芝云, 单体栋, 张方信. 重症肝炎与肠黏膜屏障. 世界华人消化杂志 2010; 18(35): 3761-3766 [DOI: 10.11569/wcjd.v18.i35.3761] [Reference Citation Analysis]
5 杨林辉, 郭华, 蔡俊, 蔡晓伟, 刘贵伦, 陈东风. 枯草杆菌肠球菌二联活菌胶囊对非酒精性脂肪性肝炎肠道菌群失调的干预作用. 世界华人消化杂志 2012; 20(20): 1873-1878 [DOI: 10.11569/wcjd.v20.i20.1873] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Llamas MA, Aller MA, Marquina D, Nava MP, Arias J. Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats. Dig Dis Sci. 2010;55:2244-2254. [PMID: 19834810 DOI: 10.1007/s10620-009-1001-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
7 Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
8 Stirnimann G, Ebadi M, Tandon P, Montano-Loza AJ. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication? Curr Gastroenterol Rep. 2018;20:50. [PMID: 30259203 DOI: 10.1007/s11894-018-0656-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Stirnimann G, Banz V, Storni F, De Gottardi A. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites. Therap Adv Gastroenterol. 2017;10:283-292. [PMID: 28203285 DOI: 10.1177/1756283x16684688] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
10 Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis. PLoS One 2015;10:e0116967. [PMID: 25658710 DOI: 10.1371/journal.pone.0116967] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
11 Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, Chen Y, Xu J, Li L. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb Ecol. 2012;63:304-313. [PMID: 21814872 DOI: 10.1007/s00248-011-9925-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
12 Santetti D, de Albuquerque Wilasco MI, Dornelles CTL, Werlang ICR, Fontella FU, Kieling CO, dos Santos JL, Vieira SMG, Goldani HAS. Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease. World J Gastroenterol 2015; 21(29): 8927-8934 [PMID: 26269683 DOI: 10.3748/wjg.v21.i29.8927] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Jiang Y, Guo C, Zhang D, Zhang J, Wang X, Geng C. The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer. J Interferon Cytokine Res 2014;34:518-25. [PMID: 24720758 DOI: 10.1089/jir.2013.0020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
14 Ghoneim AM, Mansour SM. The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling. Drug Des Devel Ther 2020;14:1469-79. [PMID: 32341640 DOI: 10.2147/DDDT.S246229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Flass T, Narkewicz MR. Cirrhosis and other liver disease in cystic fibrosis. J Cyst Fibros. 2013;12:116-124. [PMID: 23266093 DOI: 10.1016/j.jcf.2012.11.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
16 Liu J, Wu D, Ahmed A, Li X, Ma Y, Tang L, Mo D, Ma Y, Xin Y. Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals. Curr Microbiol 2012;65:7-13. [PMID: 22484797 DOI: 10.1007/s00284-012-0105-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
17 Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, Leonardi S. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13:e11215. [PMID: 24171010 DOI: 10.5812/hepatmon.11215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
18 袁林艳, 吴亚云, 李宏. 微生态制剂治疗肝衰竭内毒素血症的研究进展. 世界华人消化杂志 2013; 21(14): 1286-1291 [DOI: 10.11569/wcjd.v21.i14.1286] [Reference Citation Analysis]
19 Zuo Z, Fan H, Tang XD, Chen YM, Xun LT, Li Y, Song ZJ, Zhai HQ. Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients. Exp Ther Med 2017;14:4887-95. [PMID: 29201193 DOI: 10.3892/etm.2017.5141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chen Y, Qin N, Guo J, Qian G, Fang D, Shi D, Xu M, Yang F, He Z, Van Nostrand JD. Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis. BMC Genomics. 2014;15:753. [PMID: 25179593 DOI: 10.1186/1471-2164-15-753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]